ChemAxon Announces New CEO and Head of R&D

BUDAPEST, Hungary, May 12 — ChemAxon, a software

solutions provider for cheminformatics, today announced the appointment of

Alex Drijver as CEO. The arrival signals the companies increased focus on

business development and market position. Ferenc Csizmadia, founder and

former CEO, moves to Chairman and Head of Research and Development. The new

R&D position formalises the bridge between the customer base and the

company’s development strategy and in particular the next generation of

products under launch.

Alex joins ChemAxon with over 20 years international commercial

experience, most recently as CEO and CFO of ThalesNano Inc, a Budapest

based manufacturer of novel microfluidic based instruments for chemical

synthesis, and CFO of ComGenex, Inc., a chemistry services provider now

part of Albany Molecular.

About ChemAxon

ChemAxon is a leader in providing cheminformatics software development

platforms and applications for the biotechnology, pharmaceutical and

agrochemical industries. With core capabilities for structure

visualization, search and management, property prediction, virtual

synthesis, screening and drug design, ChemAxon focuses upon active

interaction with users and software portability to create powerful, cost

effective cross platform solutions and programming interfaces to power

modern cheminformatics and chemical communication. For more information

please visit

< | >